ベンゾジアゼピン系薬剤の世界市場レポート 2025年

ベンゾジアゼピン系薬剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で49億米ドルに成長します。予測期間の成長は、非薬物療法への消費者の嗜好の変化、依存性と乱用の可能性の低減への注目の高まり、長時間作用型ベンゾジアゼピンへの需要の高まり、ベンゾジアゼピン使用の適応拡大、個別化医療アプローチの重視などに起因すると考えられます。予測期間における主な動向としては、ベンゾジアゼピンとの併用療法の増加、バイオフィードバックおよびニューロフィードバック技術の利用の増加、舌下および経皮ベンゾジアゼピン製剤の開発、不安治療における予測モデリングのための人工知能の採用などが挙げられます。

精神疾患患者の増加は、今後のベンゾジアゼピン系薬剤市場の成長を促進すると予想されます。精神疾患には、人の認知、感情、気分に影響を与えるさまざまな状態が含まれ、多くの場合、機能障害をもたらします。精神疾患患者の増加要因には、社会的ストレス、ライフスタイルの変化、遺伝的素因、メンタルヘルスケアサービスへのアクセス制限などがあります。ベンゾジアゼピン系薬剤は、不安障害やパニック障害などの症状を和らげ、急性精神疾患エピソードの短期的な緩和を提供することで、精神疾患の症例を軽減するのに役立ちます。また、発汗、震え、息苦しさなどの症状を速やかに緩和することで、急性のパニック発作の管理にも有効であることが証明されています。例えば、2023年3月に国立生物工学情報センター（National Center for Biotechnology Information）が発表した報告書によると、18歳以上の米国の成人1,410万人が重篤な精神疾患（SMI）に罹患しており、これは米国の成人全体の5.5％に相当すると推定されています。さらに、2022年11月の国民保健サービス（National Health Service）のデータでは、17歳から19歳で精神障害の可能性が高い人の割合が増加しており、2021年の17.4％から2022年には25.7％に上昇しました。このように、精神疾患の有病率の増加がベンゾジアゼピン系薬剤市場を促進しています。

ベンゾジアゼピン系薬剤市場の主要企業は、投与量の正確性を高め、投薬ミスを減らすために、プレフィルドシリンジ注射などの高度なソリューションを開発する努力を強めています。プレフィルドシリンジ注射は、ベンゾジアゼピン系薬剤の特定用量をシリンジにあらかじめ包装し、すぐに使用できるようにあらかじめ計量しておくものです。例えば、2024年5月、Hikma Pharmaceuticals plcは、2mg/2mLと10mg/2mLのMidazolam Injection, USPを発売しました。この発売により、正確な投与オプション、複数の投与経路、呼吸抑制やオピオイド相互作用などのリスクに対応する安全性情報が提供されます。プレフィルドシリンジでのミダゾラム注射液の導入は、ベンゾジアゼピン系薬剤市場におけるドラッグデリバリーシステムの重要な進歩を意味し、利便性の向上、正確な投与、無菌状態の維持、安全性の向上を提供することで、患者ケアの向上、市場の拡大、規制遵守に貢献します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ベンゾジアゼピン系薬剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のベンゾジアゼピン系薬剤市場：成長率分析
• 世界のベンゾジアゼピン系薬剤市場の実績：規模と成長, 2019-2024
• 世界のベンゾジアゼピン系薬剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界ベンゾジアゼピン系薬剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のベンゾジアゼピン系薬剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルプラゾラム
• ジアゼパム
• ロラゼパム
• クロナゼパム
• テマゼパム
• オキサゼパム
• クロルジアゼポキシド
• その他の製品
• 世界のベンゾジアゼピン系薬剤市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界のベンゾジアゼピン系薬剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不安障害
• 発作
• 不眠症
• アルコール離脱
• その他の用途
• 世界のベンゾジアゼピン系薬剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界のベンゾジアゼピン系薬剤市場アルプラゾラムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐放性アルプラゾラム
• 即放性アルプラゾラム
• 世界のベンゾジアゼピン系薬剤市場ジアゼパムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口ジアゼパム錠
• ジアゼパム注射液
• ジアゼパム直腸ゲル
• 世界のベンゾジアゼピン系薬剤市場ロラゼパムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口ロラゼパム錠
• ロラゼパム注射剤
• 世界のベンゾジアゼピン系薬剤市場クロナゼパムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口クロナゼパム錠
• クロナゼパム崩壊錠
• 世界のベンゾジアゼピン系薬剤市場テマゼパムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口テマゼパムカプセル
• テマゼパムの液体
• 世界のベンゾジアゼピン系薬剤市場オキサゼパムの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オキサゼパム錠
• オキサゼパム経口液
• 世界のベンゾジアゼピン系薬剤市場クロルジアゼポキシドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クロルジアゼポキシドカプセル
• クロルジアゼポキシド錠
• クロルジアゼポキシド注射剤
• 世界のベンゾジアゼピン系薬剤市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニトラゼパム
• フルラゼパム
• トリアゾラム
• その他のベンゾジアゼピン系薬剤

第7章 地域別・国別分析

• 世界のベンゾジアゼピン系薬剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のベンゾジアゼピン系薬剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ベンゾジアゼピン系薬剤市場：競合情勢
• ベンゾジアゼピン系薬剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Novartis AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Dr. Reddy's Laboratories Ltd.
• Apotex Inc.
• Hikma Pharmaceuticals
• Endo International plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ベンゾジアゼピン系薬剤市場2029：新たな機会を提供する国
• ベンゾジアゼピン系薬剤市場2029：新たな機会を提供するセグメント
• ベンゾジアゼピン系薬剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Benzodiazepine drugs are a class of psychoactive medications primarily prescribed for their sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. They are commonly used to treat conditions such as anxiety disorders, panic attacks, insomnia, muscle spasms, and seizures.

The main types of benzodiazepine drug products include alprazolam, diazepam, lorazepam, clonazepam, temazepam, oxazepam, chlordiazepoxide, and others. Alprazolam, for example, is used primarily for anxiety and panic disorders. These drugs can be administered through various routes, including oral and parenteral, and are used for applications such as anxiety disorders, seizures, insomnia, alcohol withdrawal, and others. They are utilized by various end users, including hospitals, homecare settings, specialty clinics, and others.

The benzodiazepine drugs market research report is one of a series of new reports from The Business Research Company that provides benzodiazepine drugs market statistics, including benzodiazepine drugs industry global market size, regional shares, competitors with a benzodiazepine drugs market share, detailed benzodiazepine drugs market segments, market trends and opportunities, and any further data you may need to thrive in the benzodiazepine drugs industry. This benzodiazepine drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The benzodiazepine drugs market size has grown strongly in recent years. It will grow from $3.53 billion in 2024 to $3.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the rise in the prevalence of anxiety disorders, increased awareness about mental health, increased geriatric population, growth in prescription rates, and favorable reimbursement policies.

The benzodiazepine drugs market size is expected to see strong growth in the next few years. It will grow to $4.9 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to shifting consumer preferences towards non-pharmacological therapies, heightened focus on reducing dependency and abuse potential, growing demand for long-acting benzodiazepines, expanding indications for benzodiazepine use, and emphasis on personalized medicine approaches. Major trends in the forecast period include the rise of combination therapies with benzodiazepines, increasing utilization of biofeedback and neurofeedback techniques, development of sublingual and transdermal benzodiazepine formulations, and adoption of artificial intelligence for predictive modeling in anxiety treatment.

The rise in mental illness cases is expected to fuel the growth of the benzodiazepine drugs market in the future. Mental illness encompasses various conditions impacting a person's cognition, emotions, or mood, often resulting in functional impairment. Factors contributing to the increase in mental illness cases include societal stress, lifestyle changes, genetic predispositions, and limited access to mental healthcare services. Benzodiazepine drugs aid in mitigating mental illness cases by easing symptoms such as anxiety and panic disorders, offering short-term relief during acute mental health episodes. They also prove effective in managing acute panic attacks by swiftly alleviating symptoms such as sweating, trembling, and breathlessness. For instance, a report from the National Center for Biotechnology Information in March 2023 estimated that 14.1 million U.S. adults aged 18 or older had serious mental illness (SMI), representing 5.5% of all adults in the United States. Additionally, data from the National Health Service in November 2022 indicated an increase in the proportion of individuals aged 17 to 19 with a probable mental disorder, rising from 17.4% in 2021 to 25.7% in 2022. Thus, the growing prevalence of mental illness is propelling the benzodiazepine drugs market.

Leading companies in the benzodiazepine drugs market are intensifying their efforts to develop advanced solutions, such as prefilled syringe injections, to enhance dosage accuracy and reduce medication errors. Prefilled syringe injections involve pre-packaging and pre-measuring specific doses of benzodiazepine medications in syringes for immediate use. For example, in May 2024, Hikma Pharmaceuticals plc introduced Midazolam Injection, USP, in 2 mg/2 mL and 10 mg/2 mL doses. This launch offers precise dosing options, multiple administration routes, and safety information addressing risks such as respiratory depression and opioid interactions. The introduction of Midazolam Injection in prefilled syringes signifies a significant advancement in drug delivery systems within the benzodiazepine drugs market, providing enhanced convenience, accurate dosing, sterility maintenance, and improved safety, thereby contributing to improved patient care, market expansion, and regulatory compliance.

In June 2023, Eagle Pharmaceuticals Inc., a U.S.-based specialty pharmaceutical company, acquired Acacia Pharma Group plc for $0.102 billion. This acquisition, bolstered by the inclusion of BARHEMSYS and BYFAVO in its portfolio, strengthens Eagle Pharmaceuticals' position in the benzodiazepine drugs market, enhancing its presence in acute care, oncology, and procedural sedation. Acacia Pharma Group plc is a UK-based biopharmaceutical company specializing in benzodiazepine sedatives.

Major companies operating in the benzodiazepine drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals, Endo International plc, Amneal Pharmaceuticals LLC, Lupin Limited, Zydus Lifesciences Limited, Mallinckrodt Pharmaceuticals, Torrent Pharmaceuticals Ltd., Alvogen, Genentech Inc., Actavis Laboratories FL Inc., Sandoz International GmbH, Neurelis Inc.

North America was the largest region in the benzodiazepine drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benzodiazepine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the benzodiazepine drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The benzodiazepine drugs market consists of sales of Midazolam, Flurazepam, Bromazepam, Triazolam, Nitrazepam, and Etizolam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Benzodiazepine Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on benzodiazepine drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for benzodiazepine drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The benzodiazepine drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Alprazolam; Diazepam; Lorazepam; Clonazepam; Temazepam; Oxazepam; Chlordiazepoxide; Other Products
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 3) By Application: Anxiety Disorders; Seizures; Insomnia; Alcohol Withdrawal; Other Applications
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Alprazolam: Extended-release Alprazolam; Immediate-Release Alprazolam
• 2) By Diazepam: Oral Diazepam Tablets; Diazepam Injection; Diazepam Rectal Gel
• 3) By Lorazepam: Oral Lorazepam Tablets; Lorazepam Injection
• 4) By Clonazepam: Oral Clonazepam Tablets; Clonazepam Disintegrating Tablets
• 5) By Temazepam: Oral Temazepam Capsules; Liquid Form Of Temazepam
• 6) By Oxazepam: Oxazepam Tablets; Oxazepam Oral Liquid
• 7) By Chlordiazepoxide: Chlordiazepoxide Capsules; Chlordiazepoxide Tablets; Chlordiazepoxide Injection
• 8) By Other Products: Nitrazepam; Flurazepam; Triazolam; Other Benzodiazepine Drugs
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Benzodiazepine Drugs Market Characteristics

3. Benzodiazepine Drugs Market Trends And Strategies

4. Benzodiazepine Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Benzodiazepine Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Benzodiazepine Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Benzodiazepine Drugs Market Growth Rate Analysis
• 5.4. Global Benzodiazepine Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Benzodiazepine Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Benzodiazepine Drugs Total Addressable Market (TAM)

6. Benzodiazepine Drugs Market Segmentation

• 6.1. Global Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alprazolam
• Diazepam
• Lorazepam
• Clonazepam
• Temazepam
• Oxazepam
• Chlordiazepoxide
• Other Products
• 6.2. Global Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.3. Global Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anxiety Disorders
• Seizures
• Insomnia
• Alcohol Withdrawal
• Other Applications
• 6.4. Global Benzodiazepine Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Alprazolam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-release Alprazolam
• Immediate-Release Alprazolam
• 6.6. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Diazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Diazepam Tablets
• Diazepam Injection
• Diazepam Rectal Gel
• 6.7. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Lorazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Lorazepam Tablets
• Lorazepam Injection
• 6.8. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Clonazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Clonazepam Tablets
• Clonazepam Disintegrating Tablets
• 6.9. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Temazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Temazepam Capsules
• Liquid Form Of Temazepam
• 6.10. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Oxazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxazepam Tablets
• Oxazepam Oral Liquid
• 6.11. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Chlordiazepoxide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chlordiazepoxide Capsules
• Chlordiazepoxide Tablets
• Chlordiazepoxide Injection
• 6.12. Global Benzodiazepine Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nitrazepam
• Flurazepam
• Triazolam
• Other Benzodiazepine Drugs

7. Benzodiazepine Drugs Market Regional And Country Analysis

• 7.1. Global Benzodiazepine Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Benzodiazepine Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Benzodiazepine Drugs Market

• 8.1. Asia-Pacific Benzodiazepine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Benzodiazepine Drugs Market

• 9.1. China Benzodiazepine Drugs Market Overview
• 9.2. China Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Benzodiazepine Drugs Market

• 10.1. India Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Benzodiazepine Drugs Market

• 11.1. Japan Benzodiazepine Drugs Market Overview
• 11.2. Japan Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Benzodiazepine Drugs Market

• 12.1. Australia Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Benzodiazepine Drugs Market

• 13.1. Indonesia Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Benzodiazepine Drugs Market

• 14.1. South Korea Benzodiazepine Drugs Market Overview
• 14.2. South Korea Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Benzodiazepine Drugs Market

• 15.1. Western Europe Benzodiazepine Drugs Market Overview
• 15.2. Western Europe Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Benzodiazepine Drugs Market

• 16.1. UK Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Benzodiazepine Drugs Market

• 17.1. Germany Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Benzodiazepine Drugs Market

• 18.1. France Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Benzodiazepine Drugs Market

• 19.1. Italy Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Benzodiazepine Drugs Market

• 20.1. Spain Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Benzodiazepine Drugs Market

• 21.1. Eastern Europe Benzodiazepine Drugs Market Overview
• 21.2. Eastern Europe Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Benzodiazepine Drugs Market

• 22.1. Russia Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Benzodiazepine Drugs Market

• 23.1. North America Benzodiazepine Drugs Market Overview
• 23.2. North America Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Benzodiazepine Drugs Market

• 24.1. USA Benzodiazepine Drugs Market Overview
• 24.2. USA Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Benzodiazepine Drugs Market

• 25.1. Canada Benzodiazepine Drugs Market Overview
• 25.2. Canada Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Benzodiazepine Drugs Market

• 26.1. South America Benzodiazepine Drugs Market Overview
• 26.2. South America Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Benzodiazepine Drugs Market

• 27.1. Brazil Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Benzodiazepine Drugs Market

• 28.1. Middle East Benzodiazepine Drugs Market Overview
• 28.2. Middle East Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Benzodiazepine Drugs Market

• 29.1. Africa Benzodiazepine Drugs Market Overview
• 29.2. Africa Benzodiazepine Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Benzodiazepine Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Benzodiazepine Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Benzodiazepine Drugs Market Competitive Landscape And Company Profiles

• 30.1. Benzodiazepine Drugs Market Competitive Landscape
• 30.2. Benzodiazepine Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Benzodiazepine Drugs Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc
• 31.5. Eli Lilly and Company
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Otsuka Pharmaceutical Co. Ltd
• 31.9. Bausch Health Companies Inc.
• 31.10. Sun Pharmaceutical Industries Ltd.
• 31.11. Aurobindo Pharma
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Apotex Inc.
• 31.14. Hikma Pharmaceuticals
• 31.15. Endo International plc

32. Global Benzodiazepine Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Benzodiazepine Drugs Market

34. Recent Developments In The Benzodiazepine Drugs Market

35. Benzodiazepine Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Benzodiazepine Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Benzodiazepine Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Benzodiazepine Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer